Betterlife Pharma Stock Buy Hold or Sell Recommendation
| BETRF Stock | USD 0.08 0.01 9.59% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding BetterLife Pharma is 'Strong Sell'. Macroaxis provides BetterLife Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BETRF positions.
Check out BetterLife Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as BetterLife and provide practical buy, sell, or hold advice based on investors' constraints. BetterLife Pharma. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
BetterLife |
Execute BetterLife Pharma Buy or Sell Advice
The BetterLife recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BetterLife Pharma. Macroaxis does not own or have any residual interests in BetterLife Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BetterLife Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
BetterLife Pharma Trading Alerts and Improvement Suggestions
| BetterLife Pharma had very high historical volatility over the last 90 days | |
| BetterLife Pharma has some characteristics of a very speculative penny stock | |
| BetterLife Pharma has high likelihood to experience some financial distress in the next 2 years | |
| BetterLife Pharma has accumulated 34.56 K in total debt with debt to equity ratio (D/E) of 0.25, which may suggest the company is not taking enough advantage from borrowing. BetterLife Pharma has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BetterLife Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, BetterLife Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BetterLife Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BetterLife to invest in growth at high rates of return. When we think about BetterLife Pharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (12.16 M) with loss before overhead, payroll, taxes, and interest of (22.81 K). | |
| BetterLife Pharma has accumulated about 14.41 K in cash with (11.2 M) of positive cash flow from operations. |
BetterLife Pharma Returns Distribution Density
The distribution of BetterLife Pharma's historical returns is an attempt to chart the uncertainty of BetterLife Pharma's future price movements. The chart of the probability distribution of BetterLife Pharma daily returns describes the distribution of returns around its average expected value. We use BetterLife Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BetterLife Pharma returns is essential to provide solid investment advice for BetterLife Pharma.
| Mean Return | 0.01 | Value At Risk | -14.29 | Potential Upside | 16.67 | Standard Deviation | 8.49 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BetterLife Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BetterLife Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BetterLife Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BetterLife Pharma's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BetterLife otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 0.78 | |
σ | Overall volatility | 8.50 | |
Ir | Information ratio | -0.01 |
BetterLife Pharma Volatility Alert
BetterLife Pharma is showing large volatility of returns over the selected time horizon. BetterLife Pharma is a penny stock. Although BetterLife Pharma may be in fact a good investment, many penny otc stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in BetterLife Pharma. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on BetterLife instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.BetterLife Pharma Fundamentals Vs Peers
Comparing BetterLife Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BetterLife Pharma's direct or indirect competition across all of the common fundamentals between BetterLife Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as BetterLife Pharma or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of BetterLife Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing BetterLife Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BetterLife Pharma to competition |
| Fundamentals | BetterLife Pharma | Peer Average |
| Return On Equity | -44.17 | -0.31 |
| Return On Asset | -4.05 | -0.14 |
| Current Valuation | 12.42 M | 16.62 B |
| Shares Outstanding | 90.1 M | 571.82 M |
| Shares Owned By Insiders | 8.41 % | 10.09 % |
| Price To Book | 13.65 X | 9.51 X |
| Gross Profit | (22.81 K) | 27.38 B |
| EBITDA | (11.92 M) | 3.9 B |
| Net Income | (12.16 M) | 570.98 M |
| Cash And Equivalents | 14.41 K | 2.7 B |
| Total Debt | 34.56 K | 5.32 B |
| Debt To Equity | 0.25 % | 48.70 % |
| Current Ratio | 0.04 X | 2.16 X |
| Book Value Per Share | (0.12) X | 1.93 K |
| Cash Flow From Operations | (11.2 M) | 971.22 M |
| Earnings Per Share | (0.12) X | 3.12 X |
| Number Of Employees | 5 | 18.84 K |
| Beta | 1.62 | -0.15 |
| Market Capitalization | 9.49 M | 19.03 B |
| Total Asset | 1.16 M | 29.47 B |
| Net Asset | 1.16 M |
BetterLife Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BetterLife . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.1 | |||
| Day Median Price | 0.08 | |||
| Day Typical Price | 0.08 | |||
| Price Action Indicator | 0.0035 | |||
| Period Momentum Indicator | 0.007 |
About BetterLife Pharma Buy or Sell Advice
When is the right time to buy or sell BetterLife Pharma? Buying financial instruments such as BetterLife OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BetterLife Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Food Products Thematic Idea Now
Food Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Food Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Food Products Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BetterLife OTC Stock
BetterLife Pharma financial ratios help investors to determine whether BetterLife OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BetterLife with respect to the benefits of owning BetterLife Pharma security.